Pattern of Retinopathy: Although the locus of toxic damage is parafoveal in many eyes, Asian patients often show an extramacular pattern of damage. Dose: We recommend a maximum daily HCQ use of 5.0 mg/kg real weight, which correlates better with risk than ideal weight. Can you take plaquenil with lipitor Treatment of hydroxychloroquine retinopathy Apr 20, 2011 In 2002, the American Academy of Ophthalmology AAO established ocular examination guidelines for screening patients on Plaquenil therapy. Testing included a comprehensive eye exam that consisted of an assessment of the posterior segment with careful evaluation of associated macular changes or signs of retinal disease. 4 Baseline fundus photography was considered as an optional test. As a treatment for sarcoidosis, the antimalarial drug hydroxychloroquine Plaquenil® is most likely to be effective in patients with dermatologic involve-ment, joint manifestations and hypercalcemia. Due to poten-tial macular toxicity, it is recommended that patients on hydroxychloroquine have an eye examination every 6-12 months. Methotrexate. How to Succeed in Plaquenil Screenings The spectrum of OCT findings associated with the medication can make incorporating the 2016 guidelines harder than you think. Here’s help. By Marlon Demeritt, OD, Sherrol Reynolds, OD, Diana Shechtman, OD, and Jennifer Davidson, OD Risk of Toxicity: The risk of toxicity is dependent on daily dose and duration of use. There are no similar demographic data for CQ, but dose comparisons in older literature suggest using 2.3 mg/kg real weight. Plaquenil eye exam recommendations Eye screening for patients taking hydroxychloroquine., SARCOIDOSIS TREATMENT GUIDELINES Plaquenil and melatoninHypoglycemia due to maternal plaquenilPlaquenil for babesiaPlaquenil herx symptoms Here are the new recommendations for how frequent and what tests should be performed with today's standard of care for Plaquenil patients 1 Initial Baseline Screening upon first prescription Full comprehensive examination with dilation and/ or fundus photography to assess baseline macular health Plaquenil Retinopathy Screening Requirements Are You Up.. How to Succeed in Plaquenil Screenings. Hydroxychloroquine And Chloroquine Screening 2016 AAO.. Hydroxychloroquine Plaquenil is considered a disease-modifying anti-rheumatic drug DMARD. It can decrease the pain and swelling of arthritis. It may prevent joint damage and reduce the risk of long-term disability. Hydroxychloroquine is in a class of medications that was first used to prevent and treat malaria. Lupus may be cause corneal problems and 1/3 of patients may have an associated dry eye syndrome. There is also a risk of retinal blood vessel problems which could lead to decreased vision. Due to these potential eye problems, a yearly examination would be recommended. The Examiner must review a current status report by the treating physician and any supporting documents to determine the applicant’s eligibility for certification. If the applicant. meets ALL the acceptable certification criteria listed below, the Examiner can issue.